Hutom Corp

Seoul

Oncologysmall moleculeGrant-only

What changed

Study registered, no phase assigned: Feasibility of RUS Lung in MITS

10mo agoTrial registeredSep 3, 2025Source filing (opens the source filing in a new tab)

Momentum

60no change

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
R35 · $439k · non-dilutive
Jun 1, 2025
FLORIDA STATE UNIVERSITY · PI LEE, CHOOGON · NIGMS · award ends May 31, 2030 · Genetic basis of circadian rhythms and sleep disorders
NIH RePORTER · NIH RePORTER 11011659 (opens the source filing in a new tab)
Trial
NA registered
May 12, 2025
Lung Cancer · COMPLETED · sponsor: Hutom Corp · Feasibility of RUS Lung in MITS
ClinicalTrials.gov · NCT06952894 (opens the source filing in a new tab)
Grant
R01 · $422k · non-dilutive
Jul 1, 2024
UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LEE, CHENG-YU · NINDS · award ends May 31, 2029 · Regulation of generation and functions of intermediate progenitors
NIH RePORTER · NIH RePORTER 11118948 (opens the source filing in a new tab)
Grant
U01 · $557k · non-dilutive
Jun 3, 2024
DUKE UNIVERSITY · PI ROPER, JATIN · NIAID · award ends May 31, 2027 · Sex differences in delayed development of gastrointestinal fibrosis after acute radiation exposure
NIH RePORTER · NIH RePORTER 11101325 (opens the source filing in a new tab)
Grant
R01 · $510k · non-dilutive
Sep 7, 2023
DUKE UNIVERSITY · PI LEE, CHANG-LUNG · NIDCR · award ends Jun 30, 2028 · Radioprotective effect of p53 against oral mucositis
NIH RePORTER · NIH RePORTER 11111172 (opens the source filing in a new tab)
Grant
R01 · $455k · non-dilutive
May 17, 2023
ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI LEE, CHIA-HSUEH · NINDS · award ends Apr 30, 2028 · Structural analysis of the human LRRK2
NIH RePORTER · NIH RePORTER 11085993 (opens the source filing in a new tab)
Grant
R01 · $362k · non-dilutive
Jul 1, 2022
LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI LEE, CHARLES C · NIDCD · award ends Jun 30, 2027 · Bilateral integration of the auditory scene
NIH RePORTER · NIH RePORTER 11125779 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
new_entity links the trial record at 0.25{"reasons":["same therapeutic area"]}

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Study registered, no phase assigned: Feasibility of RUS Lung in MITS
10mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: Feasibility of RUS Lung in MITS
10mo agoTrial completedSource (opens the source filing in a new tab)
NIH R01 · $0.4M · Bilateral integration of the auditory scene
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.4M · Regulation of generation and functions of intermediate progenitors
May 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.5M · Radioprotective effect of p53 against oral mucositis
May 2025Grant renewalSource (opens the source filing in a new tab)
NIH U01 · $0.6M · Sex differences in delayed development of gastrointestinal fibrosis after acute radiation exposure
May 2025Grant renewalSource (opens the source filing in a new tab)
NIH R35 · $0.4M · Genetic basis of circadian rhythms and sleep disorders
May 2025New grantSource (opens the source filing in a new tab)
NIH R01 · $0.5M · Structural analysis of the human LRRK2
May 2025Grant renewalSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

R35 · $439k · non-dilutive

NA registered

R01 · $422k · non-dilutive

U01 · $557k · non-dilutive

R01 · $510k · non-dilutive

R01 · $455k · non-dilutive

R01 · $362k · non-dilutive